PHARMACOKINETICS (PK) OF VON WILLEBRAND FACTOR (VWF) IN PATIENTS WITH VON WILLEBRAND DISEASE (VWD) AFTER TREATMENT WITH RECOMBINANT VWF OR PLASMA-DERIVED VWF CONCENTRATE.

Wang, Y; Marier, J; Vasilinin, G; Berthoz, FT; Azen, G

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021; 109 (): S36